• Korro Bio director Jean Francois Formela reported selling 66,632 common shares through indirect holdings on Nov. 11-12, 2026.
• Nov. 11 sales totaled 26,587 shares at reported prices of $15 and $15.6 per share.
• Sales on Nov. 12 totaled 40,045 shares at a reported price of $14.3 per share.
• Indirect beneficial ownership totaled 706,628 common shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001030575-26-000016), on November 13, 2026, and is solely responsible for the information contained therein.